Biointron is pleased to announce a limited-time launch promotion for RushData, our integrated service platform for high-throughput antibody production and experimental data generation. Through December 31, 2026, eligible new customers can receive discounted pricing on RushData projects designed to support large-scale antibody screening and characterization.
RushData combines gene synthesis, 1-day transient CHO expression, and high-throughput characterization within a coordinated gene-to-data workflow. Depending on the selected package, experimental outputs can include expression, binding, analytical characterization, and early developability measurements. Data are returned in structured formats for downstream analysis and integration into AI- and machine-learning-driven antibody discovery workflows.
The RushData launch promotion provides two options based on project scale:
This offer applies to a single 96-well plate of RushData testing, providing access to expression, affinity, and characterization data at reduced launch pricing.
For projects involving larger candidate sets, customers ordering two or more 96-well plates can receive the first plate at no charge.
RushData was developed to address the experimental requirements of AI- and ML-driven antibody discovery, where computational workflows can generate large numbers of candidate sequences for laboratory testing.
The platform uses Biointron's 1-day CHO expression system to move antibody sequences into experimental characterization without separating gene synthesis, expression, and downstream testing into independent service workflows. RushData can be used to generate different levels of characterization data, from rapid supernatant-based screening to purified-antibody binding analysis and selected developability assays.
This integrated approach is designed to shorten the interval between sequence submission and experimental results while supporting high-throughput evaluation of antibody candidates.
Experimental validation remains an important part of computational antibody discovery. Predicted antibody properties ultimately need to be compared with measurements obtained from expressed molecules, including expression and binding data and, where required, additional analytical or developability-related parameters.
RushData links these measurements to individual antibody sequences and produces structured experimental datasets that can be used for analysis, model validation, and subsequent optimization cycles. The service includes expression and binding analysis as core components, with optional early developability profiling available depending on project requirements.
By integrating these steps within a standardized workflow, RushData provides a route from antibody sequence to experimental data in days rather than weeks.
To participate in the promotion, researchers can submit the online contact form or contact Biointron directly. A Biointron representative will follow up to discuss project requirements and apply the appropriate promotional discount.
The promotion is available from September 1 through December 31, 2026, and is limited to new customers outside China. Full eligibility and promotional terms are available on the RushData promotion page.
As larger candidate panels move from computational design into the laboratory, a……
The idea of single-cell technology is to examine B cells individually. Droplet ……
Discover how microfluidics is revolutionizing single B cell antibody screening w……
You can also contact us on the Scientist and Science Exchange marketplaces.